Showing results (241-250 of 260) with videos related to
Sort By:
Pageof 26
Biochemistry|January 26, 1993
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMRR P Meadows, D G Nettesheim, R X Xu, et al.The Journal of Pediatrics|August 21, 2025
Chair's Report: A New Twist on an Old TraditionAditi J Reis, Yonairy A Collado, Martha E Stewart, et al.Investigative Ophthalmology & Visual Science|August 18, 2025
Elevated PRDM13 Disrupts Photoreceptor Function and Survival in the Mammalian RetinaEmily R Nettesheim, Ashley A Rowe, Tiffany Yee, et al.Protein Science : a Publication of the Protein Society|February 24, 2001
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studiesA M Petros, D G Nettesheim, Y Wang, et al.Biochemistry|April 26, 1994
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activatorA P Hansen, A M Petros, R P Meadows, et al.Science (New York, N.Y.)|February 14, 1997
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosisM Sattler, H Liang, D Nettesheim, et al.Scientific Reports|May 27, 2022
The erythrocyte membrane properties of beta thalassaemia heterozygotes and their consequences for Plasmodium falciparum invasionViola Introini, Alejandro Marin-Menendez, Guilherme Nettesheim, et al.Environment International|December 17, 2008
Disposal practices for unwanted residential medications in the United StatesSusan T Glassmeyer, Elizabeth K Hinchey, Susan E Boehme, et al.Nature|May 23, 1996
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell deathS W Muchmore, M Sattler, H Liang, et al.Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.Pageof 26